Buy Torrent Pharmaceuticals; target of Rs 5581: Geojit Financial Services
TORRENT PHARM FUTURES
No trades
No trades
Headlines
Well, Medicine Sales are Rising in Double-Digits
FIIs and DIIs are piling into these four pharma stocks. Should you follow?
Substantial reduction in most cancer drugs' prices to come into effect from November 9 onwards
Neutral Torrent Pharma; target of Rs 4970: Motilal Oswal
Buy Torrent Pharmaceuticals; target of Rs 5500: Prabhudas Lilladher
Torrent Pharma eyes semaglutide launch in Brazil in 6-9 months
Platform deals on the rise in pharma and healthcare: Rothschild & Co. MD Subhakanta Bal
Torrent Pharma Q2 Profit Drops 10%; Revenue Jumps 51%
TORNTPHARM: Revenue and EBITDA surged; integration synergies support a gradual recovery and margin gains
Read this article with upgraded plans
Torrent Pharma Q2 net profit falls 10% to ₹534 crore; revenue rises 51%
Torrent Pharmaceuticals Q2 2027 Earnings Call Is Live
India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand
TORNTPHARM: Revenue rose 51%, but PAT fell as merger integration weighed on JB business
Torrent Pharma Q2 Consol Net Profit 5.34 Billion Rupees
Torrent Pharma: Nomura maintains 'Neutral' with Rs 4,670 target price ahead of Q2 results
India and EMs, Speciality Drugs to Drive Pharma Inc's September Show
Pharma Inc to See Mixed Performance in Q2
Who is Amal Kelshikar? Why did he resign from the position of Torrent Pharmaceuticals' Executive Director? Explained